Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kazia Therapeutics Ltd ADR

KZIA
Current price
0.33 USD -0.0027 USD (-0.81%)
Last closed 0.32 USD
ISIN US48669G1058
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 420 118 USD
Yield for 12 month -67.32 %
1Y
3Y
5Y
10Y
15Y
KZIA
21.11.2021 - 28.11.2021

Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company's lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia. Address: Three International Towers, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.92 USD

P/E ratio

Dividend Yield

Current Year

+374 USD

Last Year

+17 USD

Current Quarter

+3 USD

Last Quarter

+374 USD

Current Year

+374 USD

Last Year

+17 USD

Current Quarter

+3 USD

Last Quarter

+374 USD

Key Figures KZIA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 524 020 USD
Operating Margin TTM -99999999.99 %
PE Ratio
Return On Assets TTM -46.42 %
PEG Ratio
Return On Equity TTM -186.37 %
Wall Street Target Price 1.92 USD
Revenue TTM 560 USD
Book Value 0.2 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 35.6 %
Dividend Yield
Gross Profit TTM 555 USD
Earnings per share -0.37 USD
Diluted Eps TTM -0.37 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KZIA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KZIA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:4
Payout Ratio
Last Split Date 14.07.2017
Dividend Date 14.07.2017

Stock Valuation KZIA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.9427
Price Sales TTM 20393.068
Enterprise Value EBITDA -0.7133
Price Book MRQ 3.249

Financials KZIA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KZIA

For 52 weeks

0.19 USD 1.58 USD
50 Day MA 0.42 USD
Shares Short Prior Month 418 891
200 Day MA 0.35 USD
Short Ratio 0.44
Shares Short 327 782
Short Percent 1.05 %